Add BrightSurf on Google Email

Rare genetic disease may protect Ashkenazi Jews against TB

Research by University of Cambridge scientists reveals that a rare genetic disorder, Gaucher disease, provides protection against TB due to an unusual fatty chemical that acts as a microbicide. The study suggests that Ashkenazi Jews, who are more susceptible to Gaucher disease, may be less likely to contract TB infection.

SourceUniversity of Cambridge·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 6, 2023

Deer carry SARS-CoV-2 variants that are extinct in humans

A study found white-tailed deer are harboring SARS-CoV-2 variants that were once widely circulated but no longer found in humans. The deer may have become infected through contact with humans, and the virus has adapted to the deer population, potentially making it more transmissible between them.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateJan 31, 2023

Genomic screening can help detect thyroid cancer, Geisinger study finds

A Geisinger study found that genomic screening can help detect medullary thyroid cancer (MTC) in patients with RET gene variants. The research evaluated 75 patients who had the genetic results, and 12 were found to have cancer after undergoing surgery. Genomic screening provides opportunities for early detection and treatment of MTC.

SourceGeisinger Health System·JournalJAMA Otolaryngology–Head & Neck Surgery·DateJan 25, 2023

DNA from domesticated chickens is tainting genomes of wild red junglefowl

A recent study found that DNA from domesticated chickens has been introgressing into the genomes of wild red junglefowl, leading to a loss of genetic diversity. The researchers estimate that wild birds have inherited 20-50% of their genomes from domestic chickens, which could make them less resilient to environmental changes.

SourcePLOS·JournalPLOS Genetics·TypeObservational study·DateJan 19, 2023

Aging | Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization

In a mouse model of laser-induced CNV, RORα expression was highly increased in the choroidal/RPE complex post-laser, while loss or inhibition of RORα worsened CNV with increased lesion size and vascular leakage. RORα negatively regulates pathological CNV development by modulating angiogenic response and inflammatory environment.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJan 18, 2023

Genetic diagnosis helps guide care of childhood hearing loss

A recent study found that genomic testing can identify genetic causes of childhood hearing loss and provide critical information on its clinical characteristics. The researchers detected variants responsible for hearing loss in 43 different genes, and the severity of hearing loss varied by gene.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalJAMA Otolaryngology–Head & Neck Surgery·TypeObservational study·DateJan 18, 2023

Optimal genome mapping offers high-resolution method to better see, then target cancer-causing gene variants

A new study standardizes the use of optical genome mapping (OGM) for patients with blood cancers, demonstrating its potential as a frontline test for diagnosing hematologic malignancies. OGM outperforms existing tests in detecting cancer-causing gene variants and identifying additional information that can improve patient outcomes.

SourceMedical College of Georgia at Augusta University·JournalJournal of Molecular Diagnostics·DateJan 17, 2023

Support from others in stressful times can ease impact of genetic depression risk, study suggests

A recent study found that social support has a significant impact on depression risk, particularly in individuals with high genetic risk scores. The research used data from two groups: first-year doctors and recently widowed older adults, showing that those who gained social support during stressful times had lower depressive symptoms.

SourceMichigan Medicine - University of Michigan·JournalAmerican Journal of Psychiatry·TypeData/statistical analysis·DateJan 13, 2023

New approach successfully traces genomic variants back to genetic disorders

Researchers developed a genotype-first approach that traces genomic variants back to genetic disorders, discovering new relationships between genes and clinical conditions. This approach broadened traits and symptoms associated with known disorders and offered insights into newly described disorders.

SourceNIH/National Human Genome Research Institute·JournalAmerican Journal of Human Genetics·TypeLiterature review·DateJan 5, 2023

Cleft lip and palate: News from the genes

Researchers at the University of Bonn have uncovered new correlations between genetic mutations and cleft lip and palate. The study found that new mutations near the SPRY1 gene and transcription factor Musculin may contribute to disease risk, providing new insights into the biological mechanisms underlying the condition.

SourceUniversity of Bonn·JournalHuman Genetics and Genomics Advances·TypeData/statistical analysis·DateDec 15, 2022

New immune target to treat cardiovascular disease discovered

A recent study discovered a link between soluble urokinase plasminogen activator receptor (suPAR) and the development of atherosclerosis, a hardening of arteries that affects over a billion people worldwide. SuPAR was found to cause inflammation in blood vessels, leading to cardiovascular events and increasing risk of heart disease.

SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Investigation·TypeExperimental study·DateDec 15, 2022

Novel method with implications for treatment of Fukuyama muscular dystrophy, a widespread neuromuscular disorder

Researchers from Japan have developed an RNA interference method using antisense oligonucleotides to correct a genetic defect in Fukuyama Muscular Dystrophy. This approach has shown promise in treating patients with the disease, which is characterized by generalized muscle weakness and intellectual disability.

SourceFujita Health University·JournalHuman Molecular Genetics·TypeExperimental study·DateDec 12, 2022

Researchers determine genetic variants offered protection during Black Death, associated with current autoimmune disorders

A study found that genetic variants near ERAP2 and TICAM2 provided protection against Yersinia pestis, the bacterium responsible for the Black Death. These variants were also associated with improved detection and resistance to other pathogens, but at a cost: increased risk of autoimmune disorders like Crohn's disease.

Study links genetic variant to digestive disturbances in patients with Chagas disease

Researchers identified a genetic variant linked to digestive disturbances in patients with Chagas megaesophagus, a disorder characterized by esophageal dilation and loss of motility. The study suggests that increased interferon-gamma production leads to mitochondrial dysfunction, contributing to the development of the disease.

In some settings, medical masks may offer similar effectiveness to N95 respirators for preventing COVID-19 infection among health care workers

A study of over 1,000 healthcare workers found that medical masks may be as effective as N95 respirators in preventing COVID-19 infection. However, the results varied across countries and were influenced by factors such as vaccine use and variant circulating during the pandemic.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateNov 28, 2022

Oncotarget | Treasures from trash in cancer research

A new study explores the value of 'trash data' from cancer genome sequencing, identifying new strategies to uncover previously unexplored information. The researchers found that genomic and transcriptomic data contain relevant information that can help elucidate carcinogenesis and discover putative biomarkers with clinical applications.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateNov 23, 2022

Promise of better treatment for diabetes in Greenland after discovery of widespread genetic variant

A novel HNF1A gene variant has been found to cause monogenic diabetes, affecting almost seven percent of all cases in Greenland. This discovery may pave the way for precision treatment using tablet therapy with sulphonylurea, offering a simpler and cheaper alternative to insulin.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalThe Lancet Regional Health - Europe·TypeExperimental study·DateNov 15, 2022

Researchers reveal the structure of the IFT-B complex, which is essential for formation of the cilium organelle

The study reveals the structure of the 15-subunit IFT-B complex, a crucial component in cilia formation and maintenance. The complex's elongated and flexible nature is consistent with previous low-resolution reconstructions, and two configurations are identified that may drive bi-directional movement.

SourceAarhus University·JournalThe EMBO Journal·TypeExperimental study·DateNov 10, 2022

Specific modifier genes determine the effect of mutations that cause non-compaction cardiomyopathy

Researchers found that the presence of one Mindbomb1 mutation does not always lead to non-compaction cardiomyopathy, but depends on genetic context provided by other gene mutations. The study identified modifier genes contributing to disease severity and diversity in affected individuals.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation·TypeExperimental study·DateNov 7, 2022

Identifying the underlying causes of ovarian cancer

Two new discoveries led by Cedars-Sinai Cancer investigators improve understanding of ovarian cancer's development and suggest personalized therapeutic approaches. They identified four new genetic regions linked to increased ovarian cancer risk and found that some tumors may develop resistance to chemotherapy from an early stage.

SourceCedars-Sinai Medical Center·JournalJNCI Journal of the National Cancer Institute·DateNov 1, 2022

How severe is the SARS-CoV-2 Omicron BA.2 subvariant compared with earlier variants?

Researchers at Massachusetts General Hospital analyzed data from March 2020 to June 2022 to assess the severity of SARS-CoV-2 Omicron BA.2 subvariant compared to earlier variants. The study found that BA.2 was associated with lower mortality rates and reduced need for hospitalizations, invasive ventilation, and intensive care admissions.

SourceMassachusetts General Hospital·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 26, 2022